The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial
AbstractObjectivesWe will evaluate the efficacy and safety of Ivermectin in patients with mild and moderately severe COVID-19.Trial designThis is a phase 3, single-center, randomized, open-label, controlled trial with a 2-arm parallel-group design (1:1 ratio).ParticipantsThe Severe Acute Respiratory Syndrome Departments of the Shahid Mohammadi Hospital, Bandar Abbas, Iran, will screen for patients age ≥ 20 years and weight ≥35 kg for the following criteria:Inclusion criteria for patients with mild COVID-19 symptoms (outpatients)Diagnosed mild pneumonia using computed tomography (CT) and/or chest X-ray (CX-R) ima...
Source: Trials - January 4, 2021 Category: Research Source Type: clinical trials
Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program
Conditions: Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting Intervention: Drug: Interferon Beta Therapy Sponsor: Biogen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2020 Category: Research Source Type: clinical trials
